Blue Cross is headed by Mr.N.H.Israni who is our Chairman.
We are one of the leading research-based pharmaceutical companies in India with over two decades of experience in providing healthcare products to people across the globe with the aim of improving human life.

Our name today is synonymous with top quality healthcare products. We discover, develop and deliver a wide range
of innovative and highly advanced pharmaceutical products covering major therapeutic segments like Antibacterials, Pain Management, Antispasmodics, Cough & Cold Preparations,Cardiology, Diabetology, Dermatologicals,
Anti-ulcerants, Antipyretics etc. in different dosage forms at affordable cost.

 State-of-the-art Manufacturing Facilities

We have state-of-the-art manufacturing plants at Nashik and Goa in India. Our plants are modern and well equipped with spacious operational areas having adequate capacities for manufacturing world-class pharmaceutical products.

Our plants are approved by F.D.A., W.H.O and many overseas countries for compliances with current G.M.P requirements. BLUE CROSS has been bestowed with several Quality Excellence Awards for both the manufacturing plants.

Nashik Plant	Goa Factory

 World-class Quality Assurance System


We aim at achieving world-class quality standards for all our products. To accomplish this we deploy rigorous testing and elaborate in-process control procedures backed by advanced quality assurance facilities.


 Strong Research & Development

Formulation Development
Scaleup
Our unrelenting focus on research has helped us develop value added and novel drugs. Our R&D division is equipped with modern facilities. With the team consisting of dedicated and efficient research professionals with strong R&D capabilities, we conduct R & D on a broad range of therapeutic segments.


 Our Guiding Policies

World-class product quality
Continuous improvement and development in all our activities/people
Competent professional organization
Sound customer oriented marketing/distribution
Ethical business practices


 The Future Ahead

We are now poised for a new phase of growth.
To meet the challenges of the future, we have drawn up fresh strategies and planned new forays.
We aim to strengthen our presence further in therapeutic segments like Antibacterials, Anti-inflammatory, Analgesics, Nutritional, Cardiology and Diabetology by introducing new, improved molecules and dosage forms. We are also working towards introducing products in new therapeutic segments to broaden our base.